133 related articles for article (PubMed ID: 10517497)
61. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
62. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
[TBL] [Abstract][Full Text] [Related]
63. Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.
Taylor CW; Wang LM; List AF; Fernandes D; Paine-Murrieta GD; Johnson CS; Capizzi RL
Eur J Cancer; 1997 Sep; 33(10):1693-8. PubMed ID: 9389935
[TBL] [Abstract][Full Text] [Related]
64. Effect of heat-pretreatment on interleukin-2-activated killer cells for in vitro purging.
Tanaka M; Honda J; Imamura Y; Shiraishi K; Tanaka K; Oizumi K
Pathobiology; 2000; 68(3):124-8. PubMed ID: 11174069
[TBL] [Abstract][Full Text] [Related]
65. Successful in vitro purging of leukemic blasts from marrow by cortivazol, a pyrazolosteroid: a preclinical study for autologous transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Juneja HS; Harvey WH; Brasher WK; Thompson EB
Leukemia; 1995 Oct; 9(10):1771-8. PubMed ID: 7564524
[TBL] [Abstract][Full Text] [Related]
66. Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells.
Botzler C; Ellwart J; Günther W; Eissner G; Multhoff G
Exp Hematol; 1999 Mar; 27(3):470-8. PubMed ID: 10089909
[TBL] [Abstract][Full Text] [Related]
67. The protection of hemopoietic mice progenitors by WR-2721 during photodynamic therapy.
Maloisel F; Foultier MT; Patrice T; Praloran V; Oberling F; Le Bodic L
Nouv Rev Fr Hematol (1978); 1990; 32(5):357-9. PubMed ID: 1965991
[TBL] [Abstract][Full Text] [Related]
68. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
Nimgaonkar M; Kemp A; Lancia J; Ball ED
J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
[TBL] [Abstract][Full Text] [Related]
69. Purging of acute lymphoblastic leukemia by long-term marrow culture.
Douay L; Ozsahin H; Barbu V; Fabrega S; Giarratana MC; Da WM; Allieri A; Gorin NC
Prog Clin Biol Res; 1992; 377():205-13; discussion 214. PubMed ID: 1438417
[No Abstract] [Full Text] [Related]
70. High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Rugo HS; Damon LE; Ries CA; Wolf JL; Linker CA
Prog Clin Biol Res; 1994; 389():505-11. PubMed ID: 7535460
[No Abstract] [Full Text] [Related]
71. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
Gidáli J; Fehér I
Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
[TBL] [Abstract][Full Text] [Related]
72. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
[No Abstract] [Full Text] [Related]
73. Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
Singer CR; Linch DC
Leuk Res; 1987; 11(11):953-9. PubMed ID: 3320579
[TBL] [Abstract][Full Text] [Related]
74. Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation.
Thirukkumaran CM; Luider JM; Stewart DA; Cheng T; Lupichuk SM; Nodwell MJ; Russell JA; Auer IA; Morris DG
Blood; 2003 Jul; 102(1):377-87. PubMed ID: 12637331
[TBL] [Abstract][Full Text] [Related]
75. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
Lagneaux L; Marie JP; Delforge A; Socquet M; Thevenin D; Zittoun R; Stryckmans P
Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
[TBL] [Abstract][Full Text] [Related]
76. Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study.
De Souza CA; Santini G; Marino G; Nati S; Congiu AM; Vigorito AC; Damasio E
Braz J Med Biol Res; 2000 Jul; 33(7):791-8. PubMed ID: 10881054
[TBL] [Abstract][Full Text] [Related]
77. Purging in autologous hematopoietic stem cell transplantation using adenosine triphosphate (ATP) and 4-hydroperoxycyclophosphamide (4-HC).
Hatta Y; Itoh T; Baba M; Miyajima T; Shimojima H; Sawada U; Horie T
Leuk Res; 2002 May; 26(5):477-82. PubMed ID: 11916522
[TBL] [Abstract][Full Text] [Related]
78. [Long-term culture of normal and leukemia bone marrow cells].
Zhang AS; Yan Y; Zhu J
Zhonghua Nei Ke Za Zhi; 1994 Jun; 33(6):398-401. PubMed ID: 7867432
[TBL] [Abstract][Full Text] [Related]
79. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173
[TBL] [Abstract][Full Text] [Related]
80. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]